GlaxoSmithKline plc Financials

Market Capitalization £57.14 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	18.55
Forward PE	8.39
Price to Sales TTM	£1.81
Price to Book MRQ	£406.66
Enterprise to Revenue	2.23
Enterprise to EBITDA	8.11

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	10.00%
Operating Margin	30.79%
Return on Assets TTM	6.55%
Return on Equity TTM	27.10%

Income Statement

Revenue TTM	£31,529,000,960
Revenue per Share TTM	£7.72
Quarterly Revenue Growth	2.10%
Gross Profit TTM	£22,674,999,296
EBITDA	£9,150,000,000
Net Income to Common TTM	£3,152,999,936
Diluted EPS TTM	£0.76
Quarterly Earnings Growth YoY	55.30%

Balance Sheet

Total Cash MRQ	£4,485,000,192
Total Cash per Share MRQ	£1.10
Total Debt MRQ	£
Total Debt to Equity MRQ	134.99
Current Ratio MRQ	0.87
Book Value per Share MRQ	£3.47

Cash Flow

Operating Cash Flow TTM	£6,741,000,192
Levered Free Cash Flow TTM	£5,163,125,248

GSK Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	4,080,818,273
Float Shares	3,947,163,260
Avg 10 Volume	11,077,753
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	1.75%
% Held by Institutions	45.32%

Stock Price Summary

Beta	0.27
Fifty Two Week Low	£1242.50
Fifty Two Week High	£1678.68
Fifty Two Week Change	-7.54%
Day 50 MA	£1437.12
Day 200 MA	£1416.08

Dividends and Splits

Forward Annual Dividend Rate	£64.00
Forward Annual Dividend Yield	4.56%
Trailing Annual Dividend Rate	£62.00
Trailing Annual Dividend Yield	4.41%
Payout Ratio	80.16%
Dividend Date
Ex Dividend Date	2025-05-15
Last Split Factor
Last Split Date	2022-07-19